Form D · Biotechnology
GENPRIME INC
Spokane, WA · CIK 0001083845
Offering snapshot reported Jan 10, 2013 · SEC filing
- Reported sold
- $160K Offering amount: $160K
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 2, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 10, 2013 | Initial | $160,000 | No comparison | 6 | SEC filing |
| Jul 3, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 5, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-189924
Source: Form D, filed Jan 10, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Bassem Bejjani | Director |
| Rick Blake | Director |
| Johnny Humphreys | Director, Executive |
| Stephen Mcgrew | Director |
| Darby Mclean | Executive |
| John Pariseau | Director |
| Tom Simpson | Director |
| J. Buck Somes | Director, Executive |
| Tom Tiffany | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
157 South Howard Street Suite 605
Spokane, WA, 99021
Spokane, WA, 99021